Cite
MLA Citation
Katie Paul Friedman et al.. “Utility of In Vitro Bioactivity as a Lower Bound Estimate of In Vivo Adverse Effect Levels and in Risk-Based Prioritization.” Toxicological sciences, vol. 173, 2020, pp. 202–225. http://access.bl.uk/ark:/81055/vdc_100098769974.0x000015